Scalable proteomics with multiDIA resolves proteoforms in neurodegenerative disease
Abstract
Deep proteome characterization has traditionally required multidimensional chromatographic fractionation, long acquisition times and large sample amounts, thus limiting scalability. Here, we introduce multiDIA, which combines independent digestions with multiple proteases and data-independent acquisition (DIA) to increase sequence coverage without extensive chromatographic fractionation. By generating complementary and overlapping peptide representations of proteins, multiDIA identifies about 270,000 distinct peptides per sample, including 3,649 phosphosites. This is more than twice the coverage of unfractionated workflows and exceeds the coverage of multidimensional fractionation workflows that use 10-fold more material and time. We demonstrate the approach in Parkinson's disease (PD) brain samples, showing that multiDIA substantially expands sequence coverage while retaining the sensitivity, reproducibility, and scalability of DIA. This enabled the identification of disease-associated proteoform changes undetectable by single-protease DIA and the quantification of many disease-relevant post-translational modifications. MultiDIA thus enables deep, high-confidence proteome characterization from limited sample quantities without the throughput and sensitivity constraints of multidimensional fractionation.
Related
- Scalable methylome-transcriptome profiling resolves clonal organization in human hematopoiesis
- Single-cell proteomics resolves major cell populations and protein-defined chondrocyte states in the adult human osteoarthritic joint
- Discovering Subtypes of Neurodegenerative Progression with a Scalable Connectome-Constrained Dynamic Model
- Non-canonical proteoforms of the human fusiform gyrus in Alzheimers disease
- SpectraSage unveils specific proteolytic patterns of 20S on mono-ubiquitylated Tau proteoforms involved in neurodegeneration
BibTeX
@misc{kok2026scalable,
title = {{Scalable proteomics with multiDIA resolves proteoforms in neurodegenerative disease}},
author = {Orhun Kok and Corinna Friedrich and Kirsten Altig and Derek Oakley and Bradley T. Hyman and Mahlon Collins and Nikolai Slavov},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.16.756994},
url = {https://www.biorxiv.org/content/10.64898/2026.10.16.756994v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Scalable proteomics with multiDIA resolves proteoforms in neurodegenerative disease
AU - Orhun Kok
AU - Corinna Friedrich
AU - Kirsten Altig
AU - Derek Oakley
AU - Bradley T. Hyman
AU - Mahlon Collins
AU - Nikolai Slavov
PY - 2026
DA - 2026/10/16
PB - bioRxiv
DO - 10.64898/2026.10.16.756994
UR - https://www.biorxiv.org/content/10.64898/2026.10.16.756994v1
AB - Deep proteome characterization has traditionally required multidimensional chromatographic fractionation, long acquisition times and large sample amounts, thus limiting scalability. Here, we introduce multiDIA, which combines independent digestions with multiple proteases and data-independent acquisition (DIA) to increase sequence coverage without extensive chromatographic fractionation. By generating complementary and overlapping peptide representations of proteins, multiDIA identifies about 270,000 distinct peptides per sample, including 3,649 phosphosites. This is more than twice the coverage of unfractionated workflows and exceeds the coverage of multidimensional fractionation workflows that use 10-fold more material and time. We demonstrate the approach in Parkinson's disease (PD) brain samples, showing that multiDIA substantially expands sequence coverage while retaining the sensitivity, reproducibility, and scalability of DIA. This enabled the identification of disease-associated proteoform changes undetectable by single-protease DIA and the quantification of many disease-relevant post-translational modifications. MultiDIA thus enables deep, high-confidence proteome characterization from limited sample quantities without the throughput and sensitivity constraints of multidimensional fractionation.
SN - 2692-8205
ER -